Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

Medicare Part D / Prescription Drugs

Senators Release Report Concerning Postal Service Problems and Delays in Receipt of Mail-Order Drugs

On September 9, 2020, U.S. Senators Bob Casey and Elizabeth Warren released a report entitled “Rapidly Increasing Postal Service Delivery Delays for Mail-Order.” The report focuses on recent operational changes made at the U.S. Postal Service (USPS) … [Read more...] about Senators Release Report Concerning Postal Service Problems and Delays in Receipt of Mail-Order Drugs

Center Letter Re: Impact of Postal Service Delays on Medicare Beneficiaries

September 3, 2020 VIA ELECTRONIC SUBMISSION The Honorable Robert P. Casey, Jr.United States Senate393 Russell Senate Office BuildingWashington, D.C. 20510 The Honorable Elizabeth WarrenUnited States Senate309 Hart Senate Office … [Read more...] about Center Letter Re: Impact of Postal Service Delays on Medicare Beneficiaries

Final Rule for Medicare Parts C and D Includes Weakened Standards for Medicare Advantage Networks

On May 22, 2020, the Centers for Medicare & Medicaid Services (CMS) published a final rule regarding Medicare Advantage (Medicare Part C) and Part D prescription drug plans (“C & D Rule”). The rule is entitled “Medicare Program; Contract Year … [Read more...] about Final Rule for Medicare Parts C and D Includes Weakened Standards for Medicare Advantage Networks

CMS Announces Voluntary Part D Program to Reduce Insulin Out-of-Pocket Costs for Some Enrollees

In a May 26, 2020 press release, the Centers for Medicare & Medicaid Services (CMS) “announced that over 1,750 standalone Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer … [Read more...] about CMS Announces Voluntary Part D Program to Reduce Insulin Out-of-Pocket Costs for Some Enrollees

Center for Medicare Advocacy Submits Comments on Proposed Medicare Parts C and D Rule

On February 18, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule entitled Medicare and Medicaid Programs; Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare … [Read more...] about Center for Medicare Advocacy Submits Comments on Proposed Medicare Parts C and D Rule

House Passes Historic Medicare Expansion Bill – H.R. 3

Today the U.S. House of Representatives passed H.R. 3, The Elijah Cummings Lower Drug Costs Now Act, by a vote of 230 to 192. This bill, if enacted into law, would lead to a significant reduction in prescription drug costs. The resulting savings … [Read more...] about House Passes Historic Medicare Expansion Bill – H.R. 3

Medicare Experts Call for Swift Passage of HR3 to Lower Drug Prices and Improve Medicare

For Immediate Release December 9, 2019 Contact: Kata Kertesz, Esq. – kkertesz@medicareadvocacy.org, 202-293-5760 The Center for Medicare Advocacy, leading Medicare beneficiary experts, call on Congress to pass groundbreaking legislation to … [Read more...] about Medicare Experts Call for Swift Passage of HR3 to Lower Drug Prices and Improve Medicare

Speaker Pelosi Unveils Bill Authorizing Negotiation of Drug Prices and Capping Out-of-Pocket Costs

On September 19, 2019, Representative Frank Pallone, Jr., Chairman of the U.S. House Committee on Energy & Commerce, introduced the Lower Drug Costs Now Act (H.R. 3). As noted in The New York Times, the bill addresses the problem of skyrocketing … [Read more...] about Speaker Pelosi Unveils Bill Authorizing Negotiation of Drug Prices and Capping Out-of-Pocket Costs